The well-known concept of quantitative structure–activity relationships (QSAR) has been gaining significant interest in the recent years. Data, descriptors, and algorithms are the main pillars to build useful models that support more efficient drug discovery processes with in silico methods. Significant advances in all three areas are the reason for the regained interest in these models. In this book chapter we review various machine learning (ML) approaches that make use of measured in vitro/in vivo data of many compounds. We put these in context with other digital drug discovery methods and present some application examples.
CITATION STYLE
Göller, A. H., Kuhnke, L., ter Laak, A., Meier, K., & Hillisch, A. (2022). Machine Learning Applied to the Modeling of Pharmacological and ADMET Endpoints. In Methods in Molecular Biology (Vol. 2390, pp. 61–101). Humana Press Inc. https://doi.org/10.1007/978-1-0716-1787-8_2
Mendeley helps you to discover research relevant for your work.